Sign In
Buy ARCT
$5.76
-0.160 (-2.70%)
At Close: Jul 31, 2026
A Base Editing IPO from Beam Therapeutics
05:59am, Tuesday, 01'st Oct 2019
The ability to modify genes may be one of the most promising disruptive technologies there is today. As the general public learns about the potential of gene editing, retail investors will be looki
De cursos no Senac ao ensino superior: Minas
10:01am, Tuesday, 07'th Aug 2018
Antes de o chef se tornar a estrela dos restaurantes e dos reality shows, Minas Gerais j
STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics -
03:56pm, Tuesday, 12'th Dec 2017
STORM Therapeutics Exclusive Speaker Interview
